demonstrated, that the SARS-CoV-2 nucleocapsid protein bound to MASP-2 and activated complement; blockade of this interaction improved the survival of mice with COVID-19 nucleocapsid potentiated LPS-induced pneumonia (23). Here, MASP2 is linked to COVID-19.